Yu Wang
Fudan University · Department of head and neck surgery, Fudan University Shanghai Cancer Center · Sun Yat-Sen University Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
38
all conditions, ClinicalTrials.gov
NIH grants tied to them
12
150 more share only the name and are not shown
Trial papers
6879
PubMed author-name match
Trials
Studies that name Yu Wang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07780877 · Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck CancerFudan University · not yet recruiting · Head & Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma · principal investigator
- Ph3NCT06957938 · Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal CarcinomaFudan University · not yet recruiting · Laryngeal Carcinoma, Hypopharyngeal Carcinoma · principal investigator
- Ph2NCT06563999 · Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.Sun Yat-sen University · recruiting · Lung Cancer Stage III, Mutation · principal investigator
- Ph2NCT06494995 · AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic TherapyFudan University · recruiting · Head and Neck Squamous Cell Carcinoma · principal investigator
- Ph2NCT06426511 · ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLCSun Yat-sen University · recruiting · Lung Cancer, Nonsmall Cell · principal investigator
- Ph4NCT06195228 · A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid CancerFudan University · recruiting · Advanced Thyroid Cancer Patients Who Received Target Therapy · principal investigator
- Ph2NCT06077331 · A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque PsoriasisHansoh BioMedical R&D Company · unknown · Psoriasis · principal investigator
- Ph2NCT05989425 · Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid CancerFudan University · unknown · Differentiated Thyroid Cancer · principal investigator
- Ph4NCT05922033 · Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)Ohio State University · completed · Gestational Diabetes Mellitus, Pregnancy in Diabetic, Pregnancy, High Risk · principal investigator
- Ph2NCT05842746 · Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed GlioblastomaPeking Union Medical College Hospital · not yet recruiting · Glioblastoma, IDH-wildtype · principal investigator
- N/ANCT05765370 · LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)China National Center for Cardiovascular Diseases · recruiting · Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol · principal investigator
- Ph2NCT05420597 · Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal CarcinomaFudan University · unknown · Laryngeal Cancer, Hypopharyngeal Cancer · principal investigator
- Ph2NCT04995120 · Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal CarcinomaFudan University · unknown · Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Neoplasms · principal investigator
- N/ANCT04957056 · Finite Element Study of Biomechanical Changes After Unilateral Hemilamina and Facet Joint Resection of Cervical SpinePeking University Third Hospital · unknown · Intraspinal Tumor · study chair
- Ph2NCT04583020 · Neoadjuvant PD-1 in Newly Diagnosed GlioblastomaPeking Union Medical College Hospital · unknown · Glioblastoma · principal investigator
- Ph3NCT04400695 · A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2RemeGen Co., Ltd. · recruiting · Breast Cancer · principal investigator
- N/ANCT04262440 · The Effect of Caloric Supplement in the Clinical Outcomes in Acute Lung Injury PatientsTaichung Veterans General Hospital · unknown · ARDS · principal investigator
- N/ANCT04238130 · Evaluation ctDNA in Patients of Non-Small-Cell Lung Cancer Following ResectionSun Yat-sen University · completed · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT03623776 · Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.Sun Yat-sen University · withdrawn · Efficacy and Safety · principal investigator
- N/ANCT03465241 · ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGSSun Yat-sen University · completed · NSCLC · principal investigator
- N/ANCT03155451 · Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.RenJi Hospital · completed · Epithelial Ovarian Cancer · principal investigator
- N/ANCT03024892 · Intra-gallbladder or Systemic Indocyanide Green Injection Facilitate Cholecystectomy.Chang Gung Memorial Hospital · unknown · Fluorenscent Image Guided Surgery, Indocyanide Green · principal investigator
- Ph4NCT02816749 · Maggot Debridement Therapy Versus Conventional Dressing Therapy to Treat Diabetic Foot UlcersThe First Affiliated Hospital of Dalian Medical University · unknown · Diabetic Foot Ulcers · principal investigator
- N/ANCT02749565 · The Role of Endothelium A and EGFR Receptor in Fibrocytes From Asthma With Obstructive Sleep ApneaChang Gung Memorial Hospital · unknown · Asthma, OSA · principal investigator
- Ph3NCT02686151 · The Letrozole Administration During Luteal PhaseThe Affiliated Hospital of Inner Mongolia Medical University · unknown · Ovarian Hyperstimulation Syndrome · principal investigator
- N/ANCT02432248 · Effect of DHEA on Patients With Poor Ovarian RespondsThe Affiliated Hospital of Inner Mongolia Medical University · unknown · Subfertility · principal investigator
- Ph2NCT02428764 · Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung CarcinomaSun Yat-sen University · withdrawn · Lung Cancer · principal investigator
- Ph2NCT02347839 · NEoadjuvant Gefitinib fOllowed by Surgery and gefiTinib In unresectAble sTage III NSCLC With EGFR Mutations.Sun Yat-sen University · withdrawn · Lung Cancer · principal investigator
- Ph2NCT02264210 · Icotinib for Completed Resected IB NSCLC With EGFR MutationSun Yat-sen University · completed · Lung Neoplasms, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung · principal investigator
- Ph4NCT02206815 · Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"Genshan Ma · completed · Atrial Fibrillation, Coronary Artery Disease · principal investigator
- Ph3NCT01996098 · Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR MutationSun Yat-sen University · terminated · Lung Cancer · principal investigator
- N/ANCT01915641 · CPAP Improves the Walking Capacity in Patients With COPD and OSAChang Gung Memorial Hospital · completed · Walking Capacity · principal investigator
- N/ANCT01801761 · A Simplified Questionnaire to Detect OSA in COPD PatientsChang Gung Memorial Hospital · completed · OSA, COPD · principal investigator
- Ph2NCT01588704 · Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung AdenocarcinomaSi-Yu Wang · completed · Lung Cancer · principal investigator
- Ph2NCT01565538 · Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung AdenocarcinomaSi-Yu Wang · completed · Lung Cancer · principal investigator
- Ph2/Ph3NCT01528059 · Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetesfeng Zheng · unknown · Gastric Cancer, Type 2 Diabetes · principal investigator
- N/ANCT01292200 · Breast Health in Chinese American WomenGeorgetown University · completed · Breast Cancer · principal investigator
- N/ANCT00914264 · The Effects of Continuous Positive Airway Pressure on Overlap SyndromeChang Gung Memorial Hospital · completed · COPD & OSA · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 150 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Investigating the biological functions, biosynthesis, and dynamic regulations of RNA chemical modificationsR35GM162610 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · fiscal years 2026 · $423,500 awarded in 2026Same name and institution; not confirmed by an ID
- Axonal FMRP in Synaptic DevelopmentR01MH126176 · NIMH · FLORIDA STATE UNIVERSITY · fiscal years 2021 to 2025 · $398,888 awarded in 2025Same name and institution; not confirmed by an ID
- Mitochondrial dynamics in spermatogonial differentiationR01GM146587 · NIGMS · MICHIGAN STATE UNIVERSITY · fiscal years 2022 to 2025 · $313,808 awarded in 2025Same name and institution; not confirmed by an ID
- Molecular mechanism of metabolic stress in the pancreatic beta cellsR01DK141852 · NIDDK · FLORIDA STATE UNIVERSITY · fiscal years 2025 · $2,782,476 awarded in 2025Same name and institution; not confirmed by an ID
- Critical protein interactions for piRNA biogenesisR03HD110627 · NICHD · MICHIGAN STATE UNIVERSITY · fiscal years 2024 · $157,000 awarded in 2024Same name and institution; not confirmed by an ID
- Spatiotemporal transcriptomics at the maternal-fetal interface in COVID placentaR21AI169392 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · fiscal years 2022 to 2023 · $219,000 awarded in 2023Same name and institution; not confirmed by an ID
- Development of a Fragile X Syndrome model in the gerbil to study auditory dysfunctionR21DC017267 · NIDCD · FLORIDA STATE UNIVERSITY · fiscal years 2019 to 2020 · $242,176 awarded in 2020Same name and institution; not confirmed by an ID
- Collaborative Research in Integrative Cancer BiologyU01CA184902 · NCI · GEORGETOWN UNIVERSITY · fiscal years 2014 to 2018 · $521,796 awarded in 2018Same name and institution; not confirmed by an ID
- Development and afferent regulation of auditory neuronsR01DC013074 · NIDCD · FLORIDA STATE UNIVERSITY · fiscal years 2014 to 2018 · $380,000 awarded in 2018Same name and institution; not confirmed by an ID
- Impulsivity In Cocaine Abusers: Relationship to Drug Taking and Treatment OutcomeR01DA035846 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · fiscal years 2015 to 2018 · $625,447 awarded in 2018Same name and institution; not confirmed by an ID
- GH12-005: Conducting Public Health Research in ChinaU19GH000636 · CGH · CHINESE CTR-DISEASE CONTROL/PREVENTION · fiscal years 2014 to 2016 · $278,940 awarded in 2016Same name and institution; not confirmed by an ID
- Mechanism of chymase activation in endothelial cellsR21HD076289 · NICHD · LOUISIANA STATE UNIV HSC SHREVEPORT · fiscal years 2014 to 2015 · $210,600 awarded in 2015Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- A RCT TO PROMOTE MAMMOGRAPHY ADHERENCE AMONG CHINESE IMMIGRANT WOMENR01CA142941 · NCI · GEORGETOWN UNIVERSITY · PI Judy Huei-yu Wang · fiscal years 2010 to 2014Named on NCT01292200
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 20:34 UTC. The ranking covers the 200 most relevant of 6879 PubMed records, and a shared surname and initials can bring in a namesake. All 6879 on PubMed
- Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.Nat Med · 202628 citationsRCR 14.0
- 27 citationsRCR 13.5
- 19 citationsRCR 9.5
- Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.J Clin Oncol · 202616 citationsRCR 8.0
- 14 citationsRCR 7.0
- Effect of a Computer-Aided Device for Detecting Gastric Neoplasms: A Multicenter, Randomized Controlled Trial.Gastroenterology · 202614 citationsRCR 7.0
- Electrical impedance tomography-guided positive end-expiratory pressure and mortality of patients with the acute respiratory distress syndrome: the EITVent randomized clinical trial.Am J Respir Crit Care Med · 202612 citationsRCR 6.0
- Effect of esketamine on postoperative depression and anxiety in patients undergoing cardiac valve surgery: A randomised, placebo-controlled, double-blinded clinical trial.Pharmacol Res · 202510 citationsRCR 5.3
- 9 citationsRCR 4.5
- 8 citationsRCR 4.0